Kelly Gold

Insider Reports History

Location
One Kendall Square, Building 1400 West, 3 Rd Floor, Cambridge, MA
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kelly Gold:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp Chief Financial Officer Common Stock 67.9K $112K $1.65 Sep 11, 2025 Direct
Camp4 Therapeutics Corp Chief Financial Officer Stock Option (Right to Buy) 80K Apr 1, 2025 Direct

Insider Reports Filed by Kelly Gold

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Sep 11, 2025 1 $10K 4 Sep 11, 2025 Chief Financial Officer
CAMP Camp4 Therapeutics Corp Apr 1, 2025 1 $0 4 Apr 3, 2025 Chief Financial Officer
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Chief Financial Officer